Neil Cashman - 22 Sep 2025 Form 4 Insider Report for ProMIS Neurosciences Inc. (PMN)

Role
Chief Scientific Officer, Director
Signature
/s/ Max A. Milbury, Attorney in Fact for Neil Cashman
Issuer symbol
PMN
Transactions as of
22 Sep 2025
Net transactions value
$0
Form type
4
Filing time
24 Sep 2025, 08:51:55 UTC
Previous filing
12 Feb 2025
Next filing
05 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Cashman Neil Chief Scientific Officer, Director C/O PROMIS NEUROSCIENCES INC., SUITE 200, 1920 YONGE STREET, TORONTO, ONTARIO, CANADA /s/ Max A. Milbury, Attorney in Fact for Neil Cashman 24 Sep 2025 0001927064

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PMN Option (right to buy) Award $0 +165,000 $0.000000 165,000 22 Sep 2025 Common Shares 165,000 $0.4500 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to this option shall vest on September 1, 2026, and the balance shall vest ratably over 36 months